Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesJul 29, 2003View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 28, 2003View HTMLDownload DOCDownload PDF
3Initial filing by director officer or owner of more than ten percent.Jul 28, 2003View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 25, 2003View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 24, 2003View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 22, 2003View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 22, 2003View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 21, 2003View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 17, 2003View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 17, 2003View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 16, 2003View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 15, 2003View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 14, 2003View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GJul 9, 2003View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventJul 8, 2003View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GJul 7, 2003View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventJun 23, 2003View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventJun 18, 2003View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventJun 16, 2003View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventJun 12, 2003View HTMLDownload DOCDownload PDF
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsJun 10, 2003View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventMay 16, 2003View HTMLDownload DOCDownload PDF
10-QQuarterly report which provides a continuing view of a company's financial positionMay 15, 2003View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventMay 6, 2003View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventMay 1, 2003View HTMLDownload DOCDownload PDF
1-25      26-50      51-68

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information